Early Development & Construct Optimisation
Identity & Purity Testing: sequence identity, concentration, purity, and residual/impurity profiling.
Many programmes lack specialised expertise for analysing complex nucleic acid products. Our experienced scientists provide tailored analytical strategies and validated methods to ensure accurate and reliable results.
Without comprehensive testing, product quality and performance can be difficult to confirm. We provide detailed analysis of plasmid DNA, mRNA, and related components to ensure consistency and integrity.
Developing and validating analytical assays can delay programme timelines. Our team supports method development, qualification, validation, and verification to establish reliable testing workflows.
Meeting regulatory expectations requires structured stability studies and documented analytical processes. We support the design and execution of stability studies to ensure compliance and long-term product quality.
Our analytical platform supports nucleic acid products at every stage, from early characterisation through release and stability testing. We tailor testing strategies to your programme’s phase and regulatory needs, providing consistent, well- documented data that de-risks progression.
Identity & Purity Testing: sequence identity, concentration, purity, and residual/impurity profiling.
Integrity & Structural Analysis: RNA integrity, capping efficiency, poly(A) tail, and dsRNA content.
Method Development & Validation: development, qualification, and validation of fit-for-purpose methods.
Stability & Release Testing: stability study design and release testing under controlled documentation.
At Southern RNA, we integrate expertise, efficiency, and compliance into a seamless development pathway. We collaborate with clients from construct design to clinical-grade manufacturing, tailoring workflows to meet goals. Each project benefits from coordinated development, analytical support, and quality oversight, ensuring continuity and traceability. By connecting research, scale-up, and manufacturing, we reduce risk and accelerate timelines, allowing clients to focus on innovation.
Our team develops and qualifies fit-for-purpose analytical methods, using data to ensure accuracy, precision, and robustness.
We perform identity, purity, integrity, and stability testing with rigorous quality oversight and full documentation.
You receive clear, traceable data packages that support in-process control, release, and regulatory submissions.
Quality is central to Southern RNA. Our Quality Management System supports GMP operations and early-phase clinical manufacturing. From raw material qualification to final product release, every step follows documented procedures and risk assessments to ensure consistency and patient safety.
Compliance is embedded in our workflows, not just a final checkpoint. We maintain documentation systems, change management processes, and analytical verification to support regulatory submissions. By aligning quality oversight with execution, we help clients progress confidently from research to clinical supply.
Southern RNA has successfully supported multiple RNA programmes from early research through clinical supply. While client confidentiality is strictly maintained, examples of our capabilities include:
Efficiently increased production while maintaining quality and regulatory readiness for early clinical studies.
Robust, stage-aligned quality documentation and controls that support development, tech transfer, and regulatory progression.
Streamlined workflows and responsive project management to meet tight timelines without compromising quality or compliance.
Hands-on scientific support across nucleic acid design, synthesis, purification, and advanced analytical testing.
Comprehensive documentation and guidance aligned with clinical and regulatory expectations at every phase.
Our FAQ section addresses the most common technical and compliance queries, providing clarity on our capabilities, processes, and quality systems.
Yes, our facilities produce GMP-aligned and clinical-grade mRNA and plasmid DNA suitable for early-phase trials.
We follow GMP-aligned processes, robust documentation, and quality oversight to meet regulatory expectations and support submissions.
We offer flexible production from milligram-scale research material to multi-gram clinical-grade batches.
Yes, our in-house analytical team supports identity, purity, impurity profiling, and stability testing across all projects.
Absolutely. Our team develops reproducible processes for smooth transition from research-scale to GMP-aligned clinical production.
We provide plasmid DNA (pDNA) and mRNA production using flexible platforms that deliver high-quality R&D and GMP- aligned grade materials at scalable volumes.
FIND OUT MORESouthern RNA offers quality plasmid DNA and mRNA for research and clinical use. Our scalable production ensures consistent quality, aiding RNA-based therapies.
EXPLORE OUR PRODUCTS